#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#


Authors: Van Saene H. K. F. 1;  L. Silvestri 2;  De La Cal M. A. 3
Authors‘ workplace: Department of Medical Microbiology, University of Liverpool, UK 1;  Department of Anaesthesia and Critical Care, Gorizia Hospital, Italy 2;  Department of Critical Care Medicine, Getafe Hospital, Madrid, Spain 3
Published in: Anest. intenziv. Med., 16, 2005, č. 3, s. 152-160
Category: Intenzive Care Medicine - Comprehensive Report

Overview

Selective decontamination of the digestive tract [SDD] has been assessed in 54 randomised controlled trials (RCTs) and nine meta-analyses of RCTs only.The most recent meta-analysis includes 36 RCTS in 6,922 unselected patients, and shows that SDD, including enteral and parenteral antimicrobials, reduces the odds ratio for pneumonia to 0.35 [0.29 to 0.41], and mortality to 0.78 [0.68 to 0.89]. The absolute mortality reduction was 4.8%. This information implies that 5 ICU-patients need to be treated with SDD to prevent one case of pneumonia, and 21 ICU-patients need to be treated to prevent one death. Two recent large RCTs report an absolute mortality reduction of 8%, corresponding to the treatment of 12 patients with SDD to save one life. The 54 RCTs and the nine meta-analyses do not provide data for a link between SDD and antimicrobial resistance. The Cochrane Library meta-analysis reports that SDD does not lead to resistance amongst aerobic Gram-negative bacilli but, even better, the addition of enteral polymyxin/tobramycin to the parenteral antimicrobials reduces resistance compared with the parenteral antibiotics only. This is in line with a previous RCT demonstrating that enteral antimicrobials control extended spectrum beta-lactamase producing Klebsiella. Antimicrobial resistance, being a long-term issue, has been evaluated in eight studies monitoring antimicrobial resistance between two and seven years, and bacterial resistance associated with SDD has not been a clinical problem. Costs can hardly be a major concern for a manoeuvre of 6 Euros a day that reduces pneumonia by 65%, and mortality by 22% without antimicrobial resistance emerging in unselected patients. These data support level 1 evidence for SDD, allowing a grade A recommendation. The main reason for SDD not being widely used is the primacy of opinion over evidence.

Key words:
SDD (selective decomination of the digestive tract – infection in the ICU – evidence – CDC labels


Labels
Anaesthesiology, Resuscitation and Inten Intensive Care Medicine
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#